Triumph Capital Management’s Harte-Hanks HHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$186 Hold
86
﹤0.01% 1805
2026
Q1
$195 Hold
86
﹤0.01% 1767
2025
Q4
$259 Buy
+86
New +$281 ﹤0.01% 1711

Other funds holding HHS

Triumph Capital Management's HHS Position: Q2 2026 in Review

Triumph Capital Management held its Harte-Hanks (HHS) position steady in Q2 2026 at 86 shares worth $186. The position accounts for ﹤0.01% of the portfolio, ranked #1805.

Triumph Capital Management first reported a position in HHS in Q4 2025 and has held it in 3 quarters since. The position peaked at $259 in Q4 2025. 22 funds tracked by Wall St. Rank hold HHS as of Q2 2026.

  • Triumph Capital Management held 86 shares of Harte-Hanks worth $186 as of Q2 2026.
  • Triumph Capital Management left its Harte-Hanks share count unchanged in Q2 2026.
  • Harte-Hanks made up ﹤0.01% of Triumph Capital Management's portfolio in Q2 2026, its #1805 holding.
  • Triumph Capital Management first reported a position in Harte-Hanks in Q4 2025 and has held it in 3 quarters since.
  • Triumph Capital Management's Harte-Hanks position peaked at $259 in Q4 2025.
  • 22 funds tracked by Wall St. Rank held Harte-Hanks as of Q2 2026.

Based on Triumph Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.